- Filed
- Jun 5, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Jun 5, 2026 | 5.03M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.96M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.96M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$34.74K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$183.54K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.81K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$3.35M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$3.16M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$2.43M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$2.26M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.65M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.46M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.37M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.19M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $15.78K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $25.07K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $33.45M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $33.11M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.03 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.07 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.07 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $130.63K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $162.07K |
| Net Income | Q1 2026 · Mar 31, 2026 | $159.83K |
| Net Income | Q1 2026 · Mar 31, 2025 | $577.7K |